| Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers M Cobbold, N Khan, B Pourgheysari, S Tauro, D McDonald, H Osman, ... The Journal of experimental medicine 202 (3), 379-386, 2005 | 626 | 2005 |
| In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000 | 603 | 2000 |
| High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution S Chakrabarti, S Mackinnon, R Chopra, PD Kottaridis, K Peggs, ... Blood, The Journal of the American Society of Hematology 99 (12), 4357-4363, 2002 | 427 | 2002 |
| Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen R Chakraverty, K Peggs, R Chopra, DW Milligan, PD Kottaridis, ... Blood, The Journal of the American Society of Hematology 99 (3), 1071-1078, 2002 | 400 | 2002 |
| Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation KS Peggs, A Hunter, R Chopra, A Parker, P Mahendra, D Milligan, ... The Lancet 365 (9475), 1934-1941, 2005 | 346 | 2005 |
| Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+ CD25high regulatory T cells FJ Clark, R Gregg, K Piper, D Dunnion, L Freeman, M Griffiths, G Begum, ... Blood 103 (6), 2410-2416, 2004 | 284 | 2004 |
| Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in … S Tauro, C Craddock, K Peggs, G Begum, P Mahendra, G Cook, J Marsh, ... Journal of Clinical Oncology 23 (36), 9387-9393, 2005 | 271 | 2005 |
| The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia MA Cook, DW Milligan, CD Fegan, PJ Darbyshire, P Mahendra, ... Blood 103 (4), 1521-1526, 2004 | 231 | 2004 |
| Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation M Cook, D Briggs, C Craddock, P Mahendra, D Milligan, C Fegan, ... Blood 107 (3), 1230-1232, 2006 | 227 | 2006 |
| CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation KP Piper, C Horlock, SJ Curnow, J Arrazi, S Nicholls, P Mahendra, ... Blood, The Journal of the American Society of Hematology 110 (12), 3827-3832, 2007 | 148 | 2007 |
| Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte … KS Peggs, A Sureda, W Qian, D Caballero, A Hunter, A Urbano‐Ispizua, ... British Journal of Haematology 139 (1), 70-80, 2007 | 131 | 2007 |
| Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT B Pourgheysari, KP Piper, A McLarnon, J Arrazi, R Bruton, F Clark, ... Bone marrow transplantation 43 (11), 853-861, 2009 | 98 | 2009 |
| Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1 FJ Clark, L Freeman, A Dzionek, J Schmitz, D McMullan, P Simpson, ... Transplantation 75 (2), 221-225, 2003 | 85 | 2003 |
| Peripheral blood stem cell transplantation for POEMS syndrome KS Peggs, S Paneesha, PD Kottaridis, RK Chakraverty, G Tobias, ... Bone marrow transplantation 30 (6), 401-404, 2002 | 75 | 2002 |
| Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation K Raj, S Narayanan, B Augustson, A Ho, P Mehta, N Duncan, S Tauro, ... Bone marrow transplantation 35 (3), 299-301, 2005 | 64 | 2005 |
| In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Cytotherapy 3 (3), 197-201, 2001 | 63 | 2001 |
| The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British … JM Bird, R Fuge, B Sirohi, JF Apperley, A Hunter, J Snowden, ... British journal of haematology 134 (4), 385-390, 2006 | 57 | 2006 |
| Haematooncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Diagnosis and management of acute graft … FL Dignan, A Clark, P Amrolia, J Cornish, G Jackson, P Mahendra, ... Br J Haematol 158 (1), 30-45, 2012 | 56 | 2012 |
| Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning–evidence for a superior outcome using melphalan … HM Hunter, K Peggs, R Powles, A Rahemtulla, P Mahendra, J Cavenagh, ... British journal of haematology 128 (4), 496-502, 2005 | 50 | 2005 |
| Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition S Nicholls, KP Piper, F Mohammed, TR Dafforn, S Tenzer, M Salim, ... Proceedings of the National Academy of Sciences 106 (10), 3889-3894, 2009 | 46 | 2009 |
